碧水源(300070.SZ):新華資管計劃減持67.84萬股 其與國開創新合計持股降至5%以下
格隆匯 6 月 23日丨碧水源(300070.SZ)公佈,公司於今日收到公司股東新華基金-民生銀行-碧水源定增1號資產管理計劃(新華資管計劃)的資產管理人新華基金管理股份有限公司出具的《簡式權益變動報告書》,新華資管計劃於2020年6月22日,通過深圳證券交易所證券交易系統以集中競價交易方式減持公司67.84萬股股份,佔公司總股本0.02%。此次減持後,其與國開創新資本投資有限責任公司合計持有公司1.58億股股份,佔公司總股本4.99%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.